Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.54 -0.09 (-2.48%)
As of: Sep 29, 2026 · 1:57 PM EDT

Galmed Pharmaceuticals (EOCN) Non-Current Debt (2013 - 2017)

Updated

Galmed Pharmaceuticals (EOCN) reported Non-Current Debt of $150,000 for Q2 2017, down 32.4% from $222,000 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Non-Current Debt (2013 - 2017) Analysis & Trends

At the end of FY2016, Galmed Pharmaceuticals posted Non-Current Debt of $796,000, up 349.7% from FY2015.

  • Non-Current Debt has a three-year compound annual growth rate of 23.0% (FY2013 to FY2016).
  • By year, Non-Current Debt came in at $177,000 in FY2015 and $428,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Galmed Pharmaceuticals 422,361.40 422,361.40 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 150,000.00
Dec 31, 2016 796,000.00
Jun 30, 2016 222,000.00
Dec 31, 2015 177,000.00
Dec 31, 2013 428,000.00
API Access

Galmed Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=EOCN&period=max&api_key=YOUR_API_KEY